| CIPLA.NS Sector / Industry Membership |
|---|
| Sector: | Healthcare |
|---|
| Industry: | Drug Manufacturers - Major |
|---|
|
| Intraday Performance Summary |
|---|
| Top Drug Manufacturers - Major Companies by Market Cap |
|---|
| CIPLA.NS vs. Industry Leaders |
|---|
| Statistic | Industry Leader | CIPLA.NS | CIPLA.NS Rank |
|---|
| Market Capitalization | PFZ.L | 173.71B | N/A | 15
/ 268 | | P/E Ratio (ttm) | DPH.L | 4,534.38 | N/A | 36
/ 268 | | PEG Ratio (ttm, 5 yr expected) | SIGA | 71.40 | 0.97 | 20
/ 268 | | Revenue Growth (Qtrly YoY) | GODAVARI.BO | 456.30% | 19.50% | 63
/ 268 | | EPS Growth (Qtrly YoY) | 1093.HK | 3352.50% | 35.70% | 38
/ 268 | | Long-Term Growth Rate (5 yr) | PVCT | 116.00% | 21.80% | 17
/ 268 | | Return on Equity (ttm) | JBCHEM.BO | 81.60% | 16.00% | 45
/ 268 | | Long-Term Debt/Equity (mrq) | | | 15.459 | N/A | | Dividend Yield (annual) | AZN | 7.40% | N/A | N/A |
|
Currency in INR. |
|
|